Biofrontera Inc.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in co…
Drug Manufacturers - Specialty & Generic
US, Woburn [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Biofrontera Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDBiofrontera Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Biofrontera Inc..
If you want to see a demo, head over to the financial segments of AAPL